Early Detection of Lung Cancer With Low-dose Multislice Computed Tomography
1 other identifier
observational
1,334
0 countries
N/A
Brief Summary
Lung cancer is one of the leading causes of cancer-related death in Taiwan. Early diagnosis of lung cancer may improve cancer survival. Low-dose computed tomography (LDCT) was thought to be the best screening tool for lung cancer. However, there is growing concerns about radiation exposure, high cost, and high rate of false-positive screening result. Epidemiologic studies from western countries showed that cigarette smoking is the major cause of lung cancer, and other risk factors may include age, environmental pollution, occupational exposures (included of radon exposure), gender, race, and pre-existing lung diseases. Adenocarcinoma is the major type of lung cancer in Taiwan and is less attributable to smoking. The investigators need a different risk prediction model adapted to the investigators country. National Taiwan University Hospital Chu-Tung Branch initiated the lung cancer screening by LDCT since June 2015. Many people can get the LDCT screening with affordable price with the subsidy from enterprise donation. The purpose of this study is observing those participants with 2-year follow-up. Furthermore, those data may connect with another study of "Low dose computed tomography screening study in nonsmoker with risk factors for lung cancer in Taiwan" (Non-smoker study)which is implemented in other hospitals in Taiwan.For reality limiting, After one year, the enrollment rate was a lot lower than expected. We extended the enrollment time but only observe those participants for one year not two year..
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Feb 2016
Longer than P75 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2016
CompletedFirst Submitted
Initial submission to the registry
April 10, 2016
CompletedFirst Posted
Study publicly available on registry
April 28, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2019
CompletedFebruary 28, 2020
February 1, 2020
1.2 years
April 10, 2016
February 27, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Abnormal ct finding detection rate
Abnormal ct finding detection rate is defined as number of abnormal ct finding/total enroll number
1-month
Secondary Outcomes (2)
Change in Chinese 14-item Perceived Stress Scale (Chinese 14-item PSS) score
6-month
Change in Chinese Health Questionnaire-12 (CHQ-12) score
12-month
Eligibility Criteria
Patients received LDCT screening at NTUH Chu-Tung Branch
You may qualify if:
- age\>=20
- self pay the LDCT in National Taiwan University Hospital Chu-Tung Branch
- ability to understand the informed consent form for complete the questionnaires
- be willing and able to accept telephone access at the time scheduled
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ding-Cheng Chan, MD, PhD
National Taiwan University Hospital Chu-Tung Branch
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- OTHER
- Target Duration
- 52 Weeks
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 10, 2016
First Posted
April 28, 2016
Study Start
February 1, 2016
Primary Completion
May 1, 2017
Study Completion
December 1, 2019
Last Updated
February 28, 2020
Record last verified: 2020-02
Data Sharing
- IPD Sharing
- Will not share